A 3-Year Follow-Up of Pre-Emptive vs Deferred Treatment of Cytomegalovirus Disease in Renal Transplantation

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.19, Iss.5, 2000-05, pp. : 367-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pre-emptive ganciclovir preferred after renal transplantation

Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Management of human cytomegalovirus infection in transplant recipients by the pre-emptive therapy approach

By Gerna Giuseppe Baldanti Fausto Lilleri Daniele

Future Virology, Vol. 4, Iss. 2, 2009-03 ,pp. : 155-164

Future Medicine

Access to resources Recommend Favorite

Suppression of Alveolar Bone Resorption by Etidronate Treatment for Periodontal Disease: 4- to 5-Year Follow-up of Four Patients

By Takaishi Y Ikeo T Miki T Nishizawa Y Morii H

The Journal of International Medical Research, Vol. 31, Iss. 6, 2003-11 ,pp. : 575-584

Field House Publishing

Access to resources Recommend Favorite

Pre-emptive ganciclovir preferred for CMV disease after kidney transplant

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 273, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

What is the Role of NSAIDs in Pre-emptive Analgesia?

By Roth S.H.

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 629-629

Adis International

Access to resources Recommend Favorite